DXTMIDE

This brand name is authorized in Nigeria.

Active ingredients

The drug DXTMIDE contains one active pharmaceutical ingredient (API):

1	Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE
	By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency.
	Read more about Loperamide

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-2001	Capsule	DXTMIDE CAPSULES 2MG CAP 2 mg 1 X 10	59 RNW-PP-294165 DXTMIDE CAPSULES 2MG LOPERAMIDE HYDROCHLORIDE ACTIVE: Loperamide Hydrochloride 2mg LIST OF EXCIPIENTS: 1. Lactose monohydrate 2. Maize Starch 3. Talc 4. Magnesium Stearate B4-2001 Drugs ALIMENTARY TRACT AND METABOLISM Imported Products 110 OTC 11/14/2022 DANNYFAITH PHARMACY LIMITED, 23, OSENI STREET, LAWANSON, SURULERE LAGOS 7036395409 danielugb9@gmail.com JIANGXI XIERKANGTAI PHARMACEUTICAL CO. LTD, NORTH ZONE, HIGH-NEW TECHNOLOGY INDUSTRIAL ZONE, PINGXIANG, JIANGXI, China	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-2001